List of articles with "gene therapy"

REGENXBIO Q3 2026 Update

REGENXBIO Q3 2026 Update

USA Rockville gene therapy REGENXBIO RGX-202
REGENXBIO at Stifel 2026

REGENXBIO at Stifel 2026

United States New York gene therapy REGENXBIO Stifel Conference
ISCT Academy Launch

ISCT Academy Launch

Canada Vancouver gene therapy Training Academy ISCT
Nanoscope at Advanced Therapies

Nanoscope at Advanced Therapies

Boston gene therapy Nanoscope Therapeutics MOGENRY
REGENXBIO Q3 Call

REGENXBIO Q3 Call

USA financial results gene therapy REGENXBIO Rockville, MD
Liz Parrish's Gene Therapy Book

Liz Parrish's Gene Therapy Book

USA gene therapy Pacific BioViva Liz Parrish
OTXL Expands Gene Therapy Efforts

OTXL Expands Gene Therapy Efforts

United States Cambridge gene therapy Rare Disease OTXL
Viralgen CEO Transition

Viralgen CEO Transition

Spain gene therapy San Sebastián CEO Succession Viralgen
Viralgen's New CEO

Viralgen's New CEO

Spain gene therapy Viralgen Angela Ochoa Saint-Sébastien
Viralgen CEO Transition

Viralgen CEO Transition

Spain gene therapy San Sebastián Viralgen AAV
Pompe Disease Market Growth

Pompe Disease Market Growth

USA Las Vegas gene therapy Pompe Disease Enzyme Replacement
ENT Innovations Meeting

ENT Innovations Meeting

United States Los Angeles gene therapy ENT AAO-HNS
Revolutionary Deafness Treatment

Revolutionary Deafness Treatment

USA Cincinnati gene therapy Cincinnati Children's hearing restoration
Fabry Disease Therapies

Fabry Disease Therapies

None gene therapy pharmaceuticals Fabry disease
Retinitis Pigmentosa Market Growth

Retinitis Pigmentosa Market Growth

USA Las Vegas gene therapy DelveInsight retinitis pigmentosa
UCSF Approved for WASKYRA

UCSF Approved for WASKYRA

USA San Francisco gene therapy UCSF Waskyra
HSV Amplification Techniques

HSV Amplification Techniques

Japan gene therapy Tsukuba AIST HSV amplicon
BioViva's New Gene Therapy

BioViva's New Gene Therapy

USA Seattle gene therapy Aging BioViva
Innovative Gene Therapy

Innovative Gene Therapy

USA gene therapy San Sebastián Viralgen EpilepsyGTx
EpilepsyGTx and Viralgen

EpilepsyGTx and Viralgen

gene therapy Viralgen EpilepsyGTx
EpilepsyGTx and Viralgen Join Forces

EpilepsyGTx and Viralgen Join Forces

USA gene therapy San Sebastián Viralgen EpilepsyGTx
Collaborating for Epilepsy

Collaborating for Epilepsy

USA gene therapy San Sebastián Viralgen EpilepsyGTx
David Enloe Joins Rose Bio

David Enloe Joins Rose Bio

United States Rockville gene therapy Rose Bio David Enloe
tBE Therapy Success

tBE Therapy Success

Shanghai USA gene therapy CorrectSequence Base Editing
tBE Gene Editing Breakthrough

tBE Gene Editing Breakthrough

Shanghai USA gene therapy CorrectSequence Base Editing
Hearing Restoration Insights

Hearing Restoration Insights

Japan Tokyo gene therapy Hearing Loss Tokyo Residents' Lecture
First Gene Therapy Trial

First Gene Therapy Trial

gene therapy Mucolipidosis Type IV ML4 Foundation
Cell and Gene Therapy Insights

Cell and Gene Therapy Insights

Canada Toronto gene therapy Cell Therapy Xtalks
Longitude Health Alliance

Longitude Health Alliance

United States gene therapy Cell Therapy Falls Church Longitude Health
Ciongoli Joins REGENXBIO

Ciongoli Joins REGENXBIO

United States Rockville gene therapy REGENXBIO Greg Ciongoli
REGENXBIO Q2 2026 Results

REGENXBIO Q2 2026 Results

United States Rockville gene therapy REGENXBIO Duchenne Muscular Dystrophy
Galibra’s FDA Designations

Galibra’s FDA Designations

USA Boston gene therapy Galibra Neuroscience SSADH Deficiency
FibroBiologics Patent

FibroBiologics Patent

United States Houston gene therapy FibroBiologics Sox9
FAST Partners with Apertura

FAST Partners with Apertura

USA Austin gene therapy Apertura Angelman Syndrome
Longitude Health Expansion

Longitude Health Expansion

United States Washington gene therapy Clinical Trials Longitude Health
REGENXBIO Public Offering

REGENXBIO Public Offering

USA Rockville gene therapy REGENXBIO RGNX
REGENXBIO Stock Offering

REGENXBIO Stock Offering

United States gene therapy Rockville, Maryland REGENXBIO RGNX
Oligonucleotide Growth

Oligonucleotide Growth

USA Delray Beach gene therapy biotechnology Oligonucleotide Synthesis
Alport Syndrome Market Growth

Alport Syndrome Market Growth

None gene therapy Clinical Trials Alport Syndrome
MED-EL Acquires Gene Therapy

MED-EL Acquires Gene Therapy

gene therapy Austria Innsbruck MED-EL Rescue Hearing
Matthew Hemstreet CEO

Matthew Hemstreet CEO

United States gene therapy Boulder KROMATID Matthew Hemstreet
Genprex at BIO 2026

Genprex at BIO 2026

United States San Diego gene therapy Genprex BIO 2026
Rejuvenate Bio's New Funding

Rejuvenate Bio's New Funding

USA San Diego gene therapy Merck Animal Health Rejuvenate Bio
DEE Market Growth

DEE Market Growth

United States Las Vegas gene therapy Pediatric Epilepsy Developmental Encephalopathies
Advancing Gene Therapy

Advancing Gene Therapy

United States Atlanta gene therapy UT Southwestern Kleefstra Syndrome
Gene Therapy Partnership

Gene Therapy Partnership

United States gene therapy Waltham Solid Biosciences Nanomosaic
Viral Vector Manufacturing

Viral Vector Manufacturing

None gene therapy Xtalks viral vector
Innovative Gene Therapy Partnership

Innovative Gene Therapy Partnership

France gene therapy Genethon Ampersand Évry
REGENXBIO Investor Events

REGENXBIO Investor Events

USA Innovation Rockville gene therapy REGENXBIO
Ring Therapeutics at ASGCT 2026

Ring Therapeutics at ASGCT 2026

USA Cambridge gene therapy ASGCT 2026 Ring Therapeutics

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.